FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/095444 [Registered on: 29/09/2025] Trial Registered Prospectively
Last Modified On: 26/09/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) 
Study Design  Single Arm Study 
Public Title of Study   Use Of Katphaladi Kwatha In Bronchial Asthma 
Scientific Title of Study   Role Of Katphaladi Kwatha In Tamaka Shwasa(Bronchial Asthma) 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Pooja Bhatt 
Designation  PG Scholar(Kaya Chikitsa) 
Affiliation  Rishikul Campus Haridwar Uttarakhand Ayurved University (Dehradun) Haridwar 
Address  O.P.D No 1, P.G.Department of Kaya Chikitsa Rishikul Campus Haridwar Uttarakhand Ayurved University (Dehradun) Haridwar

Hardwar
UTTARANCHAL
249401
India 
Phone  8171471228  
Fax    
Email  bhattpooja70@gmail,com  
 
Details of Contact Person
Scientific Query
 
Name  ProfDr S K Tripathi 
Designation  Professor(Kaya Chikitsa) 
Affiliation  Rishikul Campus Haridwar Uttarakhand Ayurved University (Dehradun) Haridwar 
Address  O.P.D No 1, P.G.Department of Kaya Chikitsa Rishikul Campus Haridwar Uttarakhand Ayurved University (Dehradun) Haridwar

Hardwar
UTTARANCHAL
249401
India 
Phone  9568004650  
Fax    
Email  sanjaytripathi.460@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Pooja Bhatt 
Designation  PG Scholar(Kaya Chikitsa) 
Affiliation  Rishikul Campus Haridwar Uttarakhand Ayurved University (Dehradun) Haridwar 
Address  O.P.D No 1, P.G.Department of Kaya Chikitsa Rishikul Campus Haridwar Uttarakhand Ayurved University (Dehradun) Haridwar

Hardwar
UTTARANCHAL
249401
India 
Phone  8171471228  
Fax    
Email  bhattpooja70@gmail,com  
 
Source of Monetary or Material Support  
Rishikul Campus, Uttarakhand Ayurveda university, Haridwar, 249401, India 
 
Primary Sponsor  
Name  Uttarakhand Ayurved University Dehradun 
Address  Uttarakhand Ayurved University, Station Road, Harrawala, Dehradun-248001 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Pooja Bhatt  Rishikul campus, Uttarakhand Ayurved University Haridwar  O.P.D NO.1 Deptt of kayachikitsa,Rishikul campus,Uttarakhand Ayurved University,Haridwar Uttarakhand 249401 India Hardwar
Hardwar
UTTARANCHAL 
8171471228

bhattpooja70@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Rishikul Campus Haridwar Uttarakhand Ayurved University  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:J708||Respiratory conditions due to other specified external agents. Ayurveda Condition: TAMAKASVASAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Katphaladi kwatha, Reference: Sharangdhara Samhita, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 45 Days, anupAna/sahapAna: No, Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Katphaladi kwatha, Reference: Sharangdhara Samhita madhyam khand 2/43, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 45 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  20.00 Day(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Mild intermittent, mild persistent, moderate persistent asthma according to GINA guidelines.
2.Blood oxygen saturation greater than 90 percent.
3.PEFR greater than 100 litre per min. 
 
ExclusionCriteria 
Details  1.Severe persistent asthma cases according to GINA guidelines.
2.History of tuberculosis, COPD, Emphysema, other complicated disorders.
3.PEFR less than 100 litre per min.
4.Blood oxygen saturation less than 90 percent. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Improvement in subjective parameters
1.Parshva shoola
2.Kapha nishthevana
3.Asino labhate saukhyam
4.Shwasakrichta
5.Kanthoudhwanasa
6.Kasa
7.Anidra
8.Pinasa
9.Vishushkaasyata
10.Ushnaabhinanditi 
6 weeks  
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in objective parameters
1.PEFR
2.Percent of oxygen saturation.
3.ESR
4.AEC 
6 weeks 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   15/10/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Tamaka shwasa is a pranavaha sroto vikara caused by vitiated kapha and vata. It is of five types.Tamaka shwas has similar manifestations as Bronchial Asthma mentioned in modern science.Asthma is an inflammatory disorder of the airway, presenting with airway hyper responsiveness, recurrent episodes pf breathlessness, wheezing,chest tightness and coughing particularly at night and in the early morning.The disease is chronic, episodic, with variable airflow obstruction within the airways which is often reversible, either spontaneously or with treatment.The current management of Tamaka shwaas by modern medicine is not permanent as it provides short symptomatic relief.In present scenario ayurveda is the best way to treat the disease  effectively without any adverse effects and safely manage the the condition without any drug dependency. Katphaladi kwatha contains drugs which are kappa and data shamaka and does agnideepaka thereby removing the obstruction from the airways 
Close